Placebo Control
A review of key issues in pharmaceutical clinical trials
Showing posts with label
Novartis
.
Show all posts
Showing posts with label
Novartis
.
Show all posts
Tuesday, June 28, 2011
DDMAC to weigh in on trial design?
›
The FDA Law Blog has an incredibly interesting entry regarding last week's Untitled Letter from the FDA's Division of Drug Marketin...
Thursday, March 24, 2011
People Who Disagree with Me Tend to End Up Being Investigated by the Federal Government
›
I don’t think this qualifies yet as a trend, but two disturbing announcements came right back to back last week: First: As you’ve probably h...
›
Home
View web version